Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany
Author(s) -
R. Seufert,
Ludwig Sedlacek,
Barbara C. Kahl,
Michael Hogardt,
Axel Hamprecht,
Gerhard Haase,
Florian Gunzer,
A. Haas,
Silke Grauling-Halama,
Colin R. MacKenzie,
A. Essig,
Florian Stehling,
Sivagurunathan Sutharsan,
S. Dittmer,
David Killengray,
Dirk Schmidt,
Narges Eskandarian,
Eike Steinmann,
Jan Buer,
Ferry Hagen,
Jacques F. Meis,
P.M. Rath,
Jörg Steinmann
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky147
Subject(s) - aspergillus fumigatus , genotyping , azole , microbiology and biotechnology , broth microdilution , cystic fibrosis , biology , genotype , medicine , antibiotics , antifungal , minimum inhibitory concentration , gene , genetics
Aspergillus fumigatus is the most prevalent filamentous fungus in the respiratory tract of patients with cystic fibrosis (CF). The aim of this prospective multicentre study was to investigate the prevalence of azole-resistant A. fumigatus (ARAF) in respiratory secretions from CF patients across Germany and to characterize ARAF isolates by phenotypic and molecular methods.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom